RA CAPITAL MANAGEMENT, LLC Insider Trading $ACRS Aclaris Therapeutics, Inc.
Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is 10% Owner in LIPID SCIENCES INC/ ($LIPD) and 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and Director in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Verastem, Inc. ($VSTM) and 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in G1 Therapeutics, Inc. ($GTHX) and 10% Owner in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Wave Life Sciences Ltd. ($WVE) and 10% Owner in Vaxcyte, Inc. ($PCVX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in ARVINAS INC. ($ARVN) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in IMARA Inc. ($IMRA) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in Orchard Therapeutics plc ($ORTX) and Director in Orchard Therapeutics plc ($ORTX) and Director in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and Director in Nkarta, Inc. ($NKTX) and 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and Director in 89bio, Inc. ($ETNB) and 10% Owner in Pandion Therapeutics, Inc. ($PAND) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Vor Biopharma Inc. ($VOR) and 10% Owner in Dyne Therapeutics, Inc. ($DYN).
RA CAPITAL MANAGEMENT, LLC in Aclaris Therapeutics, Inc.
Trading Symbol: ACRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 2,607,719 shares
Current Value: $65,844,905
Latest Transaction: Sep 19 2016
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC in Aclaris Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, ACRS, ARVN, DRNA, DYN, EIDX, FMTX, GTHX, IMRA, INBX, INZY, ITOS, ITRM, KALA, KALV, LIPD, NKTX, ORTX, PAND, PHAT, PMVP, RARX, RYTM, STSA, SCPH, SLDB, THOR, TGTX, PCVX, VSTM, VOR, WVE, HOWL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.54 | 23,600 | 579,212 | 2,102,169 | 2.1 M to 2.1 M (-1.11 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.50 | 150,000 | 3,675,000 | 2,125,769 | 2.3 M to 2.1 M (-6.59 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.20 | 58,950 | 1,426,590 | 2,275,769 | 2.3 M to 2.3 M (-2.52 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.00 | 273,000 | 6,552,000 | 2,334,719 | 2.6 M to 2.3 M (-10.47 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.04 | 20,000 | 480,700 | 2,607,719 | 2.6 M to 2.6 M (-0.76 %) |
Feb 24 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 17.62 | 28,408 | 500,512 | 2,627,719 | 2.6 M to 2.6 M (+1.09 %) |
Feb 24 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 15.99 | 11,318 | 180,958 | 2,599,311 | 2.6 M to 2.6 M (+0.44 %) |
Jan 20 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.88 | 1,803 | 35,849 | 2,587,993 | 2.6 M to 2.6 M (+0.07 %) |
Jan 20 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.88 | 4,200 | 83,480 | 2,586,190 | 2.6 M to 2.6 M (+0.16 %) |
Jan 20 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.86 | 1,800 | 35,743 | 2,581,990 | 2.6 M to 2.6 M (+0.07 %) |
Jan 13 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.97 | 5,543 | 110,674 | 2,580,190 | 2.6 M to 2.6 M (+0.22 %) |
Jan 13 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.12 | 5,941 | 113,585 | 2,574,647 | 2.6 M to 2.6 M (+0.23 %) |
Jan 13 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 17.93 | 4,153 | 74,479 | 2,568,706 | 2.6 M to 2.6 M (+0.16 %) |
Oct 30 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.00 | 95,000 | 1,330,000 | 2,564,552 | 2.5 M to 2.6 M (+3.85 %) |
Oct 30 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.00 | 149,200 | 2,088,800 | 2,469,552 | 2.3 M to 2.5 M (+6.43 %) |
Oct 26 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.03 | 5,410 | 75,883 | 2,320,352 | 2.3 M to 2.3 M (+0.23 %) |
Oct 21 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.83 | 3,100 | 45,976 | 2,314,942 | 2.3 M to 2.3 M (+0.13 %) |
Oct 21 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.95 | 7,965 | 119,070 | 2,311,842 | 2.3 M to 2.3 M (+0.35 %) |
Oct 21 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.88 | 23,934 | 356,049 | 2,303,877 | 2.3 M to 2.3 M (+1.05 %) |
Oct 16 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.06 | 42,813 | 601,792 | 2,279,943 | 2.2 M to 2.3 M (+1.91 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 21,691 | 238,555 | 2,237,130 | 2.2 M to 2.2 M (+0.98 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 27,398 | 301,378 | 2,215,439 | 2.2 M to 2.2 M (+1.25 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 1,250,000 | 13,750,000 | 2,188,041 | 938 K to 2.2 M (+133.26 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 10.66 | 938,041 | 9,999,986 | 938,041 | 0 to 938 K |
Page: 1